| Secondary |
| Product Used For Unknown Indication |
59.4% |
| Nasopharyngitis |
18.8% |
| Depression |
9.4% |
| Lung Squamous Cell Carcinoma Stage Unspecified |
6.3% |
| Genital Herpes |
3.1% |
| Sexual Dysfunction |
3.1% |
|
| Restlessness |
28.6% |
| Haematochezia |
14.3% |
| Nasopharyngitis |
14.3% |
| Nausea |
14.3% |
| Swelling |
14.3% |
| Toxicity To Various Agents |
14.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.3% |
| Drug Use For Unknown Indication |
15.2% |
| Depression |
4.6% |
| Supplementation Therapy |
4.5% |
| Hypertension |
4.3% |
| Hiv Infection |
3.7% |
| Pain |
3.2% |
| Hormone Replacement Therapy |
3.0% |
| Medical Diet |
2.7% |
| Anxiety |
2.6% |
| Blood Cholesterol Increased |
2.6% |
| Multiple Sclerosis |
2.4% |
| Hepatitis C |
2.2% |
| Diabetes Mellitus |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Contraception |
1.9% |
| Arthralgia |
1.8% |
| Erectile Dysfunction |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Vitamin Supplementation |
1.6% |
|
| Vomiting |
14.9% |
| Weight Increased |
11.5% |
| Vision Blurred |
8.0% |
| Osteonecrosis |
6.9% |
| Pulmonary Embolism |
6.9% |
| Drug Ineffective |
5.7% |
| Liver Function Test Abnormal |
4.6% |
| Rash |
4.6% |
| Deep Vein Thrombosis |
3.4% |
| Flushing |
3.4% |
| Injection Site Bruising |
3.4% |
| Myocardial Infarction |
3.4% |
| Nausea |
3.4% |
| Pruritus |
3.4% |
| Urticaria |
3.4% |
| Uterine Prolapse |
3.4% |
| Anxiety |
2.3% |
| Cholecystitis Chronic |
2.3% |
| Death |
2.3% |
| Depression |
2.3% |
|
| Interacting |
| Lung Squamous Cell Carcinoma Stage Unspecified |
75.0% |
| Non-small Cell Lung Cancer |
25.0% |
|
| Thrombocytopenia |
60.0% |
| Drug Interaction |
20.0% |
| Off Label Use |
20.0% |
|
